Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Horama S.A.S.
DescriptionSerotype 5 rAAV delivering the retinaldehyde binding protein 1 (RLBP1) gene
Molecular Target Retinaldehyde binding protein 1 (RLBP1)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationRetinitis
Indication DetailsTreat retinitis punctata albescens
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today